Chunlei Li

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Combination Therapy

Binding Protein

Silver Nanoparticles

Top Venues

Journal of medicinal chemistry

Expert opinion on drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Chunlei Li, Ziyi Zhou, Weitao Wang, Yanqiu Zhao, Xin Yin, Yiwei Meng, Peipei Zhao, Mengmeng Wang, Xueting Liu, Xinye Wang, Shenlin Wang, Biao Ren, Lixin Zhang, Xuekui Xia
Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus . Journal of medicinal chemistry (2024)
Chunlei Li, Ziyi Zhou, Weitao Wang, Yanqiu Zhao, Xin Yin, Yiwei Meng, Peipei Zhao, Mengmeng Wang, Xueting Liu, Xinye Wang, Shenlin Wang, Biao Ren, Lixin Zhang, Xuekui Xia
Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus . Journal of medicinal chemistry 67 (2) (2024)
Chunlei Li, Ziyi Zhou, Weitao Wang, Yanqiu Zhao, Xin Yin, Yiwei Meng, Peipei Zhao, Mengmeng Wang, Xueting Liu, Xinye Wang, Shenlin Wang, Biao Ren, Lixin Zhang, Xuekui Xia
Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus . Journal of medicinal chemistry 67 (2) (2024)
Chunlei Li, Zhengjun Li, Qing Sun, Yanxiao Xiang, Anchang Liu
Severe cutaneous adverse reactions associated with immune checkpoint inhibitors therapy and anti-VEGF combination therapy: a real-world study of the FDA adverse event reporting system. Expert opinion on drug safety (2023)